Cancer is different from person to person. Each individual responds uniquely to treatment. Functional profiling uses a patient’s own cancer cells to see how they respond to different drugs or drug combinations. This testing takes place outside of a patient’s body. Cancer cells survive longer than other cells. Studying cell death provides insight into treatment. Peer reviewed publications show the success rate of functional profiling at 44 percent improvement at one year of survival. Listen as Dr. Robert Nagourney joins Dr. Mike Smith to discuss innovations in future cancer treatment.
